Menelaos Pavlou
Papers
1
Total Citations
21
H-Index
1
About
Dr. Menelaos Pavlou is a leading urologic oncologist whose research centers on the surgical management of kidney cancer, with a particular focus on nephron-sparing techniques for small renal masses. His most impactful work addresses a critical gap in urologic oncology: the lack of high-level evidence comparing minimally invasive treatment options. Dr. Pavlou spearheaded the landmark NEST (Nephron Sparing Treatment) feasibility trial, a cohort-embedded randomized controlled study that directly compared percutaneous cryoablation to robot-assisted partial nephrectomy. This innovative trial design overcame the historical challenge of poor recruitment in classical RCTs for small renal masses, demonstrating that a pragmatic, embedded approach is viable for generating comparative effectiveness data. The study, which has garnered 21 citations since its 2023 publication, provides crucial feasibility data that paves the way for larger, definitive trials. By tackling the paucity of randomized evidence in this domain, Dr. Pavlou’s work is shaping clinical decision-making for patients with small renal tumors, helping to determine the optimal balance between oncologic control and renal function preservation. His contributions are instrumental in advancing evidence-based, personalized surgical care in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1